Hefei Lifeon Pharmaceutical Co., Ltd. logo

Hefei Lifeon Pharmaceutical Co., Ltd. (003020)

Market Closed
8 Jun, 06:57
XSHE XSHE
¥
15. 57
-0.35
-2.1985%
¥
5.31B Market Cap
- P/E Ratio
0.8% Div Yield
1.58M Volume
- Eps
¥ 15.92
Previous Close
Add Transaction
Day Range
15.31 16.17
Year Range
15.31 34.56
Want to track 003020 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

003020 closed Monday lower at ¥15.57, a decrease of -2.1985% from Friday's close, completing a monthly decrease of -4.654% or -¥0.76. Over the past 12 months, 003020 stock lost -39.9769%.
003020 pays dividends to its shareholders, with the most recent payment made on May 29, 2026. The next estimated payment will be in In 2 months on Aug 29, 2026 for a total of ¥0.36.
The last earnings report, released on Oct 29, 2024, exceeded the consensus estimates by 0.2188%. On average, the company has surpassed earnings expectations by 0.158%, based on the last three reports.
Hefei Lifeon Pharmaceutical Co., Ltd. has completed 4 stock splits, with the recent split occurring on May 29, 2026.
The company's stock is traded on one exchange.

003020 Chart

People also search for

Guangzhou Wondfo Biotech Co., Ltd.
¥ 19.03
-6.9438%
China Reform Health Management Co., Ltd.
¥ 7.17
+1.2712%
Acro Biosystems Co., Ltd.
¥ 37.55
+1.4043%
EIT Environmental Development Group Co., Ltd.
¥ 18.87
-1.6163%
Huapont Life Sciences Co., Ltd.
¥ 4.55
+2.0179%

Hefei Lifeon Pharmaceutical Co., Ltd. (003020) FAQ

What is the stock price today?

The current price is ¥15.57.

On which exchange is it traded?

Hefei Lifeon Pharmaceutical Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 003020.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.8%.

What is its market cap?

As of today, the market cap is 5.31B.

Has Hefei Lifeon Pharmaceutical Co., Ltd. ever had a stock split?

Hefei Lifeon Pharmaceutical Co., Ltd. had 4 splits and the recent split was on May 29, 2026.

Hefei Lifeon Pharmaceutical Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Huanxi Cui CEO
XSHE Exchange
CNE100004BD9 ISIN
CN Country
1,456 Employees
29 May 2026 Last Dividend
29 May 2026 Last Split
- IPO Date

Overview

Hefei Lifeon Pharmaceutical Co., Ltd., established in 2002, is situated in Hefei, China, and delves into the pharmaceutical sector by focusing on the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients (APIs). The company operates comprehensively across three main segments: Pharmaceutical Industry, Pharmaceutical Wholesale and Distribution, and Pharmaceutical Retail Business. Through these segments, Hefei Lifeon Pharmaceutical extends its expertise and product offerings to meet the diverse needs in the field of pharmaceuticals, contributing significantly to healthcare and medical practices.

Products and Services

  • Active Pharmaceutical Ingredients (APIs): The company manufactures a variety of APIs, including nifedipine, paliperidone, prilocaine, methylphenidate hydrochloride, dimercaptosuccinic acid, doxazosin mesylate, paeonol, urea, felodipine, and troxerutin. These ingredients are essential for the production of various pharmaceutical products, catering to different therapeutic areas such as cardiovascular, neurological, and other conditions.
  • Medical Preparations: Hefei Lifeon Pharmaceutical offers a wide range of medical preparations across several lines including osmotic pump preparations, central nervous systems (CNS) medications, Chinese patent medicines, eye drops, external use products, and general oral medicines. This extensive portfolio demonstrates the company's capability in addressing varied medical needs and conditions.
  • Medical Intermediates: With a focus on industrial and pharmaceutical research and development, the company produces medical intermediates like 3-methoxy-1 propanethiol, mercaptosuccinic acid, domiphene, sodium dimercaptosulfonate, and others. These intermediates are crucial for the development and synthesis of pharmaceutical compounds and APIs.
  • Plant Extract Products: Recognizing the importance of natural and herbal medicine, Hefei Lifeon Pharmaceutical also deals in plant extract products such as clove oil and campanula extracts. These products find applications in traditional and complementary medicine, showcasing the company's versatility in pharmaceutical offerings.
  • Pieces: The company supplies traditional Chinese medicine pieces, including poria decoction, astragalus, honeysuckle, rose, and phellinus decoction. These pieces are used in the preparation of traditional Chinese medicine formulations, contributing to the heritage and practice of Asian medicinal art.
  • Pharmaceuticals by Therapeutic Area: Hefei Lifeon's product range extends to central nervous system drugs, cardiovascular drugs, digestive system drugs, ophthalmic drugs, and external skin drugs. This array underscores the company's dedication to developing and providing medications that tackle a variety of health issues and enhance patient care across different medical disciplines.

Contact Information

Address: Cube Factory, Hefei, China, 230088
Phone: 86 551 6535 0389